Treatment advances in early-stage primary systemic anaplastic large cell lymphoma
10.3760/cma.j.issn.1006-9801.2016.07.018
- VernacularTitle:早期原发系统间变性大细胞淋巴瘤治疗进展
- Author:
Ximei ZHANG
;
Zhiyong YUAN
- Publication Type:Journal Article
- Keywords:
Lymphoma,large-cell,anaplastic;
Drug therapy,combination;
Radiotherapy;
Transplantation
- From:
Cancer Research and Clinic
2016;28(7):493-497
- CountryChina
- Language:Chinese
-
Abstract:
Primary systemic anaplastic large cell lymphoma (ALCL) is a subtype of rare and heterogeneous clinical entity, extremely rare in early stage of disease. There is no standard treatment yet. Based on retrospective studies, systematic chemotherapy followed by involved field radiation after chemotherapy is the mainstay of treatment. The role of radiotherapy in the treatment of early stage ALCL remains unclear due to lack of prospective studies. So do the optimal chemotherapy regimens and hematopoietic stem cell transplantation. The paper will review these issues.
